Skip to main content

Table 4 List of complements and complement-regulating proteins

From: Comparative proteomic analysis of glomerular proteins in primary and bucillamine-induced membranous nephropathy

Accession ID

NCBInr DB

Accession ID

GenBank DB

Protein name

Sequence coverage (%)

Peptide match (n)

PLA2R (+) pMN patients (n = 6)/Transplantation donors (n = 5) ratio (Ratio variability [%])

PLA2R (‒) pMN patients (n = 6)/Transplantation donors (n = 5) ratio (Ratio variability [%])

BCL-induced sMN patients (n = 6)/Transplantation donors (n = 5) ratio (Ratio variability [%])

115298678

 

C3

23

38

7.49 (129.06)

4.98 (135.45)

3.21 (91.36)

443671

 

C4A

12

17

100**

100**

100**

40737478

 

C4A3

14

5

100**

100**

100**

119576392

 

C9

12

7

7.13 (87.45)

7.51 (78.82)

2.69 (85.74)

118442839

 

CFHR1

14

4

 

7.36 (68.49)

46.38** (0)

767910533

 

CFHR5

10

6

100**

100**

100**

578815184

 

Clusterin

25

13

2.15 (112.32)

2.14 (127.33)

1.49 (98.18)

809019

X05309.1

CR1

3

3

2.05 (54.36)

0.24 (51.06)

4.28 (26.67)

194383558

AK303793.1

C4BPA

13

7

1.79 (106.65)

2.88 (121.81)

1.22 (84.37)

13477169

 

Vitronectin

18

7

2.72 (92.66)

2.37 (103.65)

2.87 (89.85)

  1. BCL: bucillamine; C4BPA: C4b-binding protein α chain; CFHR: complement factor H-related protein; CR: complement receptor; DB: data base; NCBInr: National Cancer for Biotechnology Information non-redundant; PLA2R: phospholipase A2 receptor; pMN: primary membranous nephropathy; sMN: secondary membranous nephropathy
  2. **P < 0.01